CLS-AX

· Clearside Biomedical, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for CLS-AX, covering 2023-08-21 to 2025-07-25. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate Suprachoroidally Administered CLS-AX in the Treatment of Neovascular Age-Related Macular Degeneration [Phase 2]

See pricing